Comparison of combination of dipyridamole and dobutamine during echocardiography with thallium scintigraphy to improve viability detection

This publication has 25 references indexed in Scilit:

• Identification of Viable Myocardium
  Circulation, 1996
• Combined low dose dipyridamole-dobutamine stress echocardiography to identify myocardial viability
  Journal of the American College of Cardiology, 1996
• Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability
  The American Journal of Cardiology, 1993
• Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest
  The American Journal of Cardiology, 1992
• Myocardial viability. What does it mean and how do we measure it?
  Circulation, 1991
• Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography
  Journal of the American College of Cardiology, 1990
• Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
  Journal of the American Society of Echocardiography, 1989
• Selective enhancement of function of stunned myocardium by increased flow.
  Circulation, 1986
• Beta-adrenergic stimulation reverses postischemic myocardial dysfunction without producing subsequent functional deterioration
  The American Journal of Cardiology, 1985
• The extraction of thallium-201 by the myocardium.
  Circulation, 1977